Day One Biopharmaceuticals, Inc vs Johnson & Johnson — Stock Comparison

DAWN
Day One Biopharmaceuticals, Inc
$21.53
vs
JNJ
Johnson & Johnson
$227.19
▼ 1.16%
Q·Score Winner
Johnson & Johnson
JNJ7.1/10vs 4.5/10

Q·Score Breakdown

4.5
Bearish
Overall
7.1
Bullish
0.5
Quality
9.3
9.2
Health
6.5
7.3
Growth
5.1
3.7
Valuation
7.3
2.5
Sentiment
6.5
DAWN

Clean balance sheet with low leverage (0.0× debt-to-equity).

currently unprofitable (-68% margin).

JNJ

High-quality business with 26% return on equity and 22% profit margins.

earnings contracting 53% year-over-year.

Analyst Consensus

HOLD
Target $21.50 (-0.1%)
6 analysts
BUY
Target $252.42 (+11.1%)
24 analysts

Fundamentals

DAWN
JNJ
Trailing P/E
26.3×
-112.4×
Forward P/E
17.9×
-67.8%
Profit Margin
21.8%
89.1%
Gross Margin
68.0%
-22.7%
ROE
26.4%
83.9%
Revenue Growth
9.9%
Earnings Growth
-52.9%
-1.75
Beta
0.33
Price / Book
$2.2B
Market Cap
$546.9B
$6 – $22
52-Week Range
$146 – $252

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →